Clinical Trials Directory

Trials / Unknown

UnknownNCT02894229

The Stress Reduction Intervention Study

The Mindfulness Intervention and Repeated Acute Stress (MIRAS) Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Ohio University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The primary purpose of the present study is to investigate the relationship between mindfulness and stress habituation. The investigators propose to measure the effect of mindfulness on stress habituation by randomly assigning participants to a 6-week mindfulness-based stress reduction group intervention, a cognitive-behavioral skills group comparison intervention, or a waitlist control condition followed by repeated acute psychosocial stress testing (2 laboratory sessions on 2 separate days). Saliva will be collected from participants throughout both laboratory testing sessions to measure HPA axis activation (an essential stress-responsive system), along with other measures of physiological and psychological stress (e.g., heart rate, blood pressure, emotions). Mediators and moderators of treatment outcome will be examined. The cognitive-behavioral skills group condition is an appropriate comparison group due to the well-documented efficacy of cognitive-behavioral interventions on stress.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness Based Stress ReductionA modified version of traditional MBSR. The current study's version of MBSR is shortened to 6-weeks.
BEHAVIORALCognitive-Behavioral Therapy (CBT) GroupA 6-week, 2-hour per group, skills group that focuses on various cognitive-behavioral skills for stress reduction (e.g., progressive muscle relaxation; cognitive restructuring).

Timeline

Start date
2016-08-01
Primary completion
2019-07-01
Completion
2019-07-01
First posted
2016-09-09
Last updated
2018-04-04

Source: ClinicalTrials.gov record NCT02894229. Inclusion in this directory is not an endorsement.

The Stress Reduction Intervention Study (NCT02894229) · Clinical Trials Directory